Literature DB >> 30449135

Myeloid-Derived Suppressor Cells and Costimulatory Molecules in Children With Allergic Rhinitis.

Asmaa M Zahran1, Khaled Saad2, Khalid I Elsayh2, Abobakr Abdelmoghny3, Mohamed Diab Aboul-Khair4, Ali Sobhy5, Yasser F Abdel-Raheem2, Osama M El-Asheer2, Amira A El-Houfey6,7, Mohamd A Alblihed8, Ibrahim Al-Neami9.   

Abstract

OBJECTIVES: : The aim of this study is to assess the level of myeloid-derived suppressor cells (MDSCs) and the expression of costimulatory molecules CD80 and CD86 on monocytes and their ligands (CD28) on T-lymphocytes in children with allergic rhinitis (AR).
METHODS: : The study included 60 children with AR and 50 controls. Flow cytometry was performed to analyze MDSCs and the expression of costimulatory molecules CD80 and CD86 on monocytes and their ligands (CD28) on T-lymphocytes.
RESULTS: : The percentages of total and monocytic MDSCs and the expression of costimulatory molecule CD86 on monocytes were significantly higher in children with AR than in healthy controls. In addition, the expressions of CD28 on CD4+ and CD8+ were significantly elevated in AR patients.
CONCLUSION: : The present study demonstrated that the percentages of MDSCs were significantly elevated in AR children. Moreover, the expressions of CD28 on CD4+ and CD8+ were significantly higher in children with AR.

Entities:  

Keywords:  CD28; CD86; allergic rhinitis; children; myeloid-derived suppressor cells

Mesh:

Substances:

Year:  2018        PMID: 30449135     DOI: 10.1177/0003489418812902

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.

Authors:  Simon H Murch
Journal:  Med Hypotheses       Date:  2020-08-07       Impact factor: 1.538

2.  Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia.

Authors:  Asmaa M Zahran; Azza Shibl; Amal Rayan; Mohamed Alaa Eldeen Hassan Mohamed; Amira M M Osman; Khaled Saad; Khaled Hashim Mahmoud; Aliaa M A Ghandour; Khalid I Elsayh; Omnia El-Badawy
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.